4SC AG: 4SC publishes Q1 2024 report
4SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage c…
4SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage c…
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
The X-Smart Pro+ endodontic motor with integrated Apex Locator was recently honored with the international iF Design Awa…
Removes the requirement to conduct paediatric clinical studies when the development of the medicine is not needed or is…
Resminostat (Kinselby) as a maintenance therapy is now clinically proven to postpone disease progression in advanced Cut…
VG901 is the first and only clinical-stage therapy designed to deliver a functional CNGA1 genÂe to retinal photoceptor t…
- Pentavere hat die branchenweit erste von Experten begutachtete (peer-reviewed) Arbeit veröffentlicht, in der KI und gr…
Fast Track designation awarded by the FDA serves as an external validation of the potential of NOX-A12 for unmet need in…
Wolfgang Wienand, currently CEO of Swiss CDMO Siegfried Holding AG, will become Chief Executive Officer of Lonza in the…
Gold is not only an excellent means of preserving value for investors but is also becoming increasingly important in med…